Pharmaceutical News

RSS

Drugs delivered by nanoparticles hold promise for targeted treatment of many diseases, including cancer

Drugs delivered by nanoparticles hold promise for targeted treatment of many diseases, including cancer. However, the particles have to be injected into patients, which has limited their usefulness so far.

27 Nov 2013

Nonabsorbable antibiotics effective in eradicating CRE colonization

Orally administered, nonabsorbable antibiotics were effective in eradicating carbapenem-resistant Enterobacteriaceae (CRE) colonization, according to a new study published in the December issue of the American Journal of Infection Control, a publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

27 Nov 2013

Multivitamin supplements can reduce incidence of pre-eclampsia

Pre-eclampsia is a serious complication of pregnancy that currently affects 6-8% of all pregnancies in Australia. Griffith Health Institute researchers have recently found that multivitamin supplements, including those that contain selenium, can reduce the incidence of PE, especially for overweight mothers.

27 Nov 2013

Typhoon survivors in Tacloban vaccinated against measles and polio

Children in Tacloban – the city hit hardest by Typhoon Haiyan – were vaccinated against measles and polio in the first phase of a mass campaign by the Government of the Philippines with support from UNICEF, the World Health Organization, and other partners. They also received Vitamin A supplements to help improve their immunity against infections.

27 Nov 2013

Drug interactions impact use of cholesterol-lowering statin drugs

A new study has found that many people who stopped taking cholesterol-lowering statin drugs were also taking an average of three other drugs that interfered with the normal metabolism of the statins.

27 Nov 2013

Merck announces approval of NOXAFIL delayed-release tablets by FDA

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved NOXAFIL® (posaconazole) 100 mg delayed-release tablets.

27 Nov 2013

Inhibitor compounds could form basis of new treatments for such diseases as MRSA, anthrax

Inhibitor compounds developed by UC Irvine structural biologists and Northwestern University chemists have been shown to bolster the ability of antibiotics to treat deadly bacterial diseases such as MRSA and anthrax.

27 Nov 2013

FDA accepts Purdue Pharma's Targiniq ER Tablets CII NDA for review

Purdue Pharma L.P. today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application for Targiniq ER (oxycodone HCl/naloxone HCl controlled-release) Tablets CII, for the management of chronic pain.

27 Nov 2013

EU-funded project develops new type of vaccine to tackle HIV virus infection

AIDS research has attempted many strategies to tackle the HIV virus infection. Now, a new type of vaccine developed within an EU-funded project, called EuroNeut-41, is based on one of the envelope proteins of the HIV virus, called the gp41 protein. What makes it interesting it that it is directly responsible for the fusion of the HIV virus into human cells. By integrating the gp41 protein into the vaccine, researchers try to trigger the production of antibodies that would block the entrance of HIV into human cells

27 Nov 2013

Study shows dl-3n-butylphthalide may have protective effects against diffuse brain injury

Dl-3n-butylphthalide can effectively treat cerebral ischemia; however, the mechanisms underlying the effects of dl-3n-butylphthalide on microcirculation disorders following diffuse brain injury remain unclear.

27 Nov 2013

HPV vaccine coverage among teens still remains low than other recommended vaccinations

Barriers to human papillomavirus (HPV) vaccination among adolescents in the U.S. range from financial concerns and parental attitudes to social influences and concerns about the vaccination's effect on sexual behavior, according to a review of the available medical literature published by JAMA Pediatrics, a JAMA Network publication.

26 Nov 2013

Biocon receives regulatory approval for biosimilar product, trastuzumab

Mylan Inc. today announced that its partner Biocon has received approval for a Mylan-Biocon trastuzumab product from the Drug Controller General of India. This is the first regulatory approval for a Mylan-Biocon developed biosimilar product.

26 Nov 2013

Researchers analyze effects of MXE drug usage

Researchers from Sweden have attempted to create an understanding to the subjective effects from use of Methoxetamine (MXE), a drug belonging to a class known as "legal highs" or "research chemicals," and available for purchase on the Internet.

26 Nov 2013

FDA grants priority review status to Avedro's riboflavin ophthalmic solution/KXL system

Avedro Inc, a Boston-based ophthalmic medical device and pharmaceutical company announces that it received notification from the U.S. Food and Drug Administration stating that their NDA for riboflavin ophthalmic solution/KXL system has been filed, and has been granted priority review status. The priority review status places the application action date at March 15th, 2014.

25 Nov 2013

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Medicines Agency's: Committee for Medicinal Products for Human Use has adopted a positive opinion for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas.

25 Nov 2013

Antidepressants in pregnancy do not cause autism, study finds

New research cannot establish a close connection between the use of antidepressant medication - the so-called SSRIs - during the course of pregnancy and the risk of having a child with autism.

25 Nov 2013

Researchers discover how type 2 diabetes drug metformin actually works

Researchers from St. Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with researchers at McMaster University in Canada, are reportedly the first to discover how the type 2 diabetes drug metformin actually works, providing a molecular understanding that could lead to the development of more effective therapies. Mass spectrometry technologies from AB SCIEX, a global leader in analytical technologies, played a critical role in the analysis that led to this breakthrough finding.

25 Nov 2013

CHMP recommends approval of Otsuka's Deltyba for pulmonary multidrug-resistant tuberculosis

Otsuka Pharmaceutical Co., Ltd. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Deltyba (delamanid) in combination with a WHO recommended optimized background regimen for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB). The CHMP opinion will help form the basis for a European Commission decision expected early next year.

25 Nov 2013

Diabetes patients who receive medications by mail are less likely to visit emergency room

Patients with diabetes who received prescribed heart medications by mail were less likely to visit the emergency room than those patients who picked up prescriptions in person, according to a new Kaiser Permanente study published in the American Journal of Managed Care.

25 Nov 2013

Steroid injections given before premature birth may increase child's mental health risks

Steroid injections given to pregnant women before premature birth may increase the child's risk of later behavioural and emotional difficulties, a study has found.

23 Nov 2013

Pharmaceutical News

Drugs delivered by nanoparticles hold promise for targeted treatment of many diseases, including cancer

Nonabsorbable antibiotics effective in eradicating CRE colonization

Multivitamin supplements can reduce incidence of pre-eclampsia

Typhoon survivors in Tacloban vaccinated against measles and polio

Drug interactions impact use of cholesterol-lowering statin drugs

Merck announces approval of NOXAFIL delayed-release tablets by FDA

Inhibitor compounds could form basis of new treatments for such diseases as MRSA, anthrax

FDA accepts Purdue Pharma's Targiniq ER Tablets CII NDA for review

EU-funded project develops new type of vaccine to tackle HIV virus infection

Study shows dl-3n-butylphthalide may have protective effects against diffuse brain injury

HPV vaccine coverage among teens still remains low than other recommended vaccinations

Biocon receives regulatory approval for biosimilar product, trastuzumab

Researchers analyze effects of MXE drug usage

FDA grants priority review status to Avedro's riboflavin ophthalmic solution/KXL system

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

Antidepressants in pregnancy do not cause autism, study finds

Researchers discover how type 2 diabetes drug metformin actually works

CHMP recommends approval of Otsuka's Deltyba for pulmonary multidrug-resistant tuberculosis

Diabetes patients who receive medications by mail are less likely to visit emergency room

Steroid injections given before premature birth may increase child's mental health risks

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News